A New Scoring Algorithm to Assess the Prognosis of Primary and Metastatic Breast Cancer with HER2-low Expression

被引：0
|
作者：
Miao, Jiaxian [1 ]
Shang, Jiuyan [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
187
引用
收藏
页码：S222 / S224
页数：3
相关论文
共 50 条
  • [21] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Horisawa, Nanae
    Adachi, Yayoi
    Takatsuka, Daiki
    Nozawa, Kazuki
    Endo, Yuka
    Ozaki, Yuri
    Sugino, Kayoko
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (02) : 234 - 241
  • [22] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Nanae Horisawa
    Yayoi Adachi
    Daiki Takatsuka
    Kazuki Nozawa
    Yuka Endo
    Yuri Ozaki
    Kayoko Sugino
    Ayumi Kataoka
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Masataka Sawaki
    Hiroji Iwata
    Breast Cancer, 2022, 29 : 234 - 241
  • [23] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Mengyuan Cai
    Ming Li
    Hong Lv
    Shuling Zhou
    Xiaoli Xu
    Ruohong Shui
    Wentao Yang
    BMC Cancer, 23
  • [24] HER2-Low Breast Cancer: Evolution of HER2 expression from Primary Tumor to Distant Metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S107 - S109
  • [25] Inter-Metastasis Heterogeneity of HER2-Low in Metastatic Breast Cancer
    Jaffer, Shabnam
    Bhardwaj, Swati
    LABORATORY INVESTIGATION, 2024, 104 (03) : S179 - S180
  • [26] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [27] HER2-low metastatic breast cancer: molecular insights and therapeutic strategies
    Esteva, Francisco J.
    Jaffer, Shabnam
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
  • [28] ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.
    Liu, Yueping
    Lv, Hong
    Shen, Mengjia
    Shui, Ruohong
    Ye, Feng
    Meng, Yue
    Jia, Ying
    Liu, Chao
    An, Shun
    Yuan, Xiaoying
    Li, Xingmin
    Yang, Wentao
    Bu, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm
    Yang, Charlie
    Brezden-Masley, Christine
    Joy, Anil Abraham
    Sehdev, Sandeep
    Modi, Shanu
    Simmons, Christine
    Henning, Jan-Willem
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [30] The Dynamic of HER2-low Expression during Breast Cancer Progression
    Anderson, Sarah
    Bartow, Brooke
    Huang, Xiao
    Wei, Shi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S89 - S89
12345